- Home
- GDTC vs WYY Comparison
GDTC vs WYY Comparison
Compare GDTC & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- WYY
- Stock Information
- Founded
- GDTC 2018
- WYY 1991
- Country
- GDTC Singapore
- WYY United States
- Employees
- GDTC N/A
- WYY N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- WYY EDP Services
- Sector
- GDTC Health Care
- WYY Technology
- Exchange
- GDTC Nasdaq
- WYY Nasdaq
- Market Cap
- GDTC 21.5M
- WYY 33.6M
- IPO Year
- GDTC 2023
- WYY 1998
- Fundamental
- Price
- GDTC $1.89
- WYY $2.99
- Analyst Decision
- GDTC Buy
- WYY Strong Buy
- Analyst Count
- GDTC 1
- WYY 1
- Target Price
- GDTC $5.00
- WYY $7.00
- AVG Volume (30 Days)
- GDTC 18.1K
- WYY 58.6K
- Earning Date
- GDTC 01-01-0001
- WYY 08-14-2025
- Dividend Yield
- GDTC N/A
- WYY N/A
- EPS Growth
- GDTC N/A
- WYY N/A
- EPS
- GDTC N/A
- WYY N/A
- Revenue
- GDTC $368,838.00
- WYY $142,582,209.00
- Revenue This Year
- GDTC $5.37
- WYY $9.05
- Revenue Next Year
- GDTC N/A
- WYY $12.24
- P/E Ratio
- GDTC N/A
- WYY N/A
- Revenue Growth
- GDTC N/A
- WYY 24.03
- 52 Week Low
- GDTC $1.20
- WYY $2.19
- 52 Week High
- GDTC $4.05
- WYY $6.25
- Technical
- Relative Strength Index (RSI)
- GDTC 35.89
- WYY 34.63
- Support Level
- GDTC $1.85
- WYY $2.99
- Resistance Level
- GDTC $1.95
- WYY $3.23
- Average True Range (ATR)
- GDTC 0.10
- WYY 0.18
- MACD
- GDTC -0.02
- WYY -0.01
- Stochastic Oscillator
- GDTC 23.53
- WYY 1.75
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.